Medina Manuel Hidalgo holds the role of Director at Guardant Health, Inc. (GH). Hidalgo's filing history also covers BRISTOL MYERS SQUIBB CO (BMY). Hidalgo has reported 20 insider filings with the SEC since 2025. The most recent filing was in August 2026.
Every role Medina Manuel Hidalgo has reported on a Form 4, reconstructed from the filings themselves. Reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
Updated Aug 30, 2026
Medina Manuel Hidalgo is Director of Guardant Health, Inc. (GH). 20 SEC Form 4 filings on record going back to 2025, most recently on 18 August 2026. Most recent open-market trade: sold $123K of GH on 6 August 2026. Lifetime open-market sales: $922K.
Every recent SEC Form 4 transaction Medina Manuel Hidalgo has reported, most recent first.
InsiderAlpha's records for Medina Manuel Hidalgo go back to 2025: 20 primary Form 4 filings, an average of 10.0 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Insiders who reported open-market trades in the last 12 months at the companies Medina Manuel Hidalgo files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Medina Manuel Hidalgo is a corporate insider, tracked as Director of Guardant Health, Inc. (GH). InsiderAlpha holds 20 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
4 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases and 10 open-market sales ($922K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
950 shares @ $163.95$156K